The University of Chicago Header Logo

Connection

Ravi Salgia to Anthracyclines

Back to Details
This is a "connection" page, showing publications Ravi Salgia has written about Anthracyclines.
Ravi Salgia
Connection Strength
0.145
Anthracyclines
  1. Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer. J Clin Oncol. 2010 May 20; 28(15):2598-603.
    View in: PubMed
    Score: 0.092
  2. An Updated Review on Radiation Treatment Management in Thymus Cancers. Clin Lung Cancer. 2022 Nov; 23(7):561-570.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.